Showing 1 - 10 of 646
Emerging markets stand strong
Oped, Kristalina Georgieva and Mohammed Al-Jadaan, Published on 12/02/2026
» It used to be that when advanced economies sneezed, emerging markets caught a cold. That is no longer true. Following recent global shocks, such as the post-pandemic inflation surge and a new wave of tariffs, emerging markets have held up well. Inflation has continued to slow, currencies have generally retained their value, and debt issuance costs have remained at manageable levels. There has been no sign of the kind of financial turbulence that came with past economic shocks.
Time for Indo-Pacific unity is now
Oped, Akihisa Nagashima, Published on 26/12/2025
» We are living in an age of global disruption. Supply chains are being reconfigured to avoid dependence on any one producer or country. Trade ties are being upended by high and unpredictable tariffs (and the threat of more). Longstanding alliances are being strained by doubts about partners' reliability.
Baht bets rising
Oped, Postbag, Published on 15/12/2025
» Re: "BoT measures to halt rapid baht uptick", (Business, Dec 5).
Derelict outpost
Oped, Postbag, Published on 03/12/2025
» Re: Toxic threat sweeps all before it", (BP, Dec 1). Your recent report left me more than a little confused about a village I have known for 37 years. The description bore little resemblance to the village I visit maybe four times a week when I visit my local supermarket or withdraw money from the ATM. Those golden years of rafting took place before the highway was constructed over the mountain range.
Why is North Korea courting Russian tourists?
Oped, Saahil Menon, Published on 13/08/2025
» Hoping to replenish state coffers with much-needed foreign exchange reserves and offset the sharp post-Covid decline in Chinese tour groups, the Hermit Kingdom has set its sights on inquisitive holiday-makers from an ideologically aligned Russia.
Losing the narrative
Oped, Editorial, Published on 04/08/2025
» Since the border clashes between Thailand and Cambodia began and up until the recently brokered ceasefire, Thailand has struggled to present its position to the world.
Flat fare flaw
Oped, Postbag, Published on 10/07/2025
» Re: "20-baht flat rate fare gets the nod", (BP, July 9).
Stepping up HIV fight
Oped, Editorial, Published on 30/06/2025
» The recent news of Gilead Sciences' groundbreaking new HIV preventative drug, Lenacapavir, offers a beacon of hope in the fight against HIV. With a remarkable 96% efficacy in reducing HIV infection and the convenience of only two injections per year, Lenacapavir holds the potential to be a true game-changer in the global effort to halt the transmission of HIV.
Africa's example to end malaria
Oped, Jean Kaseya, Published on 26/05/2025
» Despite being preventable and curable, malaria has continued to claim African lives. In 2023, the continent accounted for about 95% of the 597,000 deaths from malaria worldwide, 76% of which were children under the age of five.
Unite to solve neglected diseases
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.